Functional Magnetic Neuromuscular Stimulation vs. Routine Physiotherapy in the Critically Ill for Prevention of ICU Acquired Muscle Loss: A Randomised Controlled Trial
- PMID: 39459511
- PMCID: PMC11509331
- DOI: 10.3390/medicina60101724
Functional Magnetic Neuromuscular Stimulation vs. Routine Physiotherapy in the Critically Ill for Prevention of ICU Acquired Muscle Loss: A Randomised Controlled Trial
Abstract
Background and Objectives: Muscle loss is a known complication of ICU admission. The aim of the study was to investigate the effect of neuromuscular functional magnetic stimulation (FMS) on quadriceps muscle thickness in critically ill patients. Materials and Methods: Among ICU patients one quadriceps was randomized to FMS (Tesla Stym, Iskra Medical, Ljubljana, Slovenia) stimulation and the other to control care. Quadriceps thickness was measured by ultrasound (US) in transversal and longitudinal planes at enrolment, Days 3-5, and Days 9-12. The trial stopped early following an interim analysis comparing muscle thickness differences between groups using repeated measures ANOVA. Results: Of 18 patients randomized, 2 died before completing the trial. The final analysis reported included 16 patients (female 38%, age 68 ± 10 years, SOFA 10.8 ± 2.7). Three mild skin thermal injuries were noted initially, which were later avoided with proper positioning of FMS probe. Primary outcome comparison showed that quadriceps thickness in transversal and longitudinal planes decreased in the non-stimulated legs and, but it did not change in FMS legs (-4.1 mm (95%CI: -9.4 to -0.6) vs. -0.7 mm (95%CI: -4.1 to -0.7) (p = 0.03) and -4.4 mm (95%CI: -8.9 to -1.1) vs. -1.5 mm (95%CI: -2.6 to -2.2) (p = 0.02), respectively) (ANOVA difference between groups p = 0.036 and 0.01, respectively). Conclusions: In the critically ill, neuromuscular FMS is feasible and safe with precautions applied to avoid possible skin thermal injury. FMS decreases the loss of quadriceps muscle thickness.
Keywords: ICU acquired weakness; functional magnetic stimulation; muscle ultrasound; skeletal muscle.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Feasibility of neuromuscular electrical stimulation in critically ill patients.J Crit Care. 2014 Dec;29(6):1082-8. doi: 10.1016/j.jcrc.2014.06.024. Epub 2014 Jun 30. J Crit Care. 2014. PMID: 25108833
-
Medical high-protein nutrition therapy and loss of muscle mass in adult ICU patients: A randomized controlled trial.Clin Nutr. 2021 Apr;40(4):1562-1570. doi: 10.1016/j.clnu.2021.02.021. Epub 2021 Feb 23. Clin Nutr. 2021. PMID: 33743292 Clinical Trial.
-
Neuromuscular electrical stimulation prevents muscle wasting in critically ill comatose patients.Clin Sci (Lond). 2015 Mar;128(6):357-65. doi: 10.1042/CS20140447. Clin Sci (Lond). 2015. PMID: 25296344 Clinical Trial.
-
Effects of neuromuscular electrical stimulation in critically ill patients: A systematic review and meta-analysis of randomised controlled trials.Aust Crit Care. 2020 Mar;33(2):203-210. doi: 10.1016/j.aucc.2019.04.003. Epub 2019 May 31. Aust Crit Care. 2020. PMID: 31160215
-
Therapeutic Potential of Electromyostimulation (EMS) in Critically Ill Patients-A Systematic Review.Front Physiol. 2022 May 9;13:865437. doi: 10.3389/fphys.2022.865437. eCollection 2022. Front Physiol. 2022. PMID: 35615672 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous